SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Neurobiological Tech (NTII)
NTII 0.00010000.0%Mar 7 3:00 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Howard Frederick who wrote (160)7/6/1997 5:25:00 PM
From: scaram(o)uche  Read Replies (1) of 1494
 
Howard:

First, let me say how much I appreciate your clear comments and focus regarding NTII. However, I _have_ wavered on NTII. I have openly expressed disdain in this thread for management (the Price and Mohr Show).

I had hoped that the company could generate the resources to GENEROUSLY support the work of Lipton with memantine derivatives and to sponsor work in additional labs. It hasn't happened. I very much wish that I had taken my $7/share and split. You are correct..... I have never come out and said "sell"; we have been blind-sided at least three times by the old management team, and my information flow could be characterized as "catch up" rather than insightful.

In the next breath......... at this market cap, I'm not selling. Freiman deserves a chance, and, IMO, he has ammo to work with.

IMO, you're wise to write off Dynorphin.

Rick
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext